Real-Life Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany

被引：0
|
作者：
Dworak, Markus
Gruenberger, Jean-Bernard
Bader, Giovanni
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1101-P
引用
收藏
页码：A285 / A285
页数：1
相关论文
共 50 条
  • [41] Improved glycemic control with real-life CGM use in patients with type 1 diabetes
    Ellis, Samuel L.
    Voelmle, Mary
    Ritchie, Peter
    Gottlieb, Peter
    Gutin, Raymond
    Garg, Satish
    DIABETES, 2008, 57 : A116 - A116
  • [42] Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus
    Forst, T.
    Dworak, M.
    Berndt-Zipfel, C.
    Loeffler, A.
    Klamp, I.
    Mitry, M.
    Pfuetzner, A.
    DIABETES OBESITY & METABOLISM, 2013, 15 (06): : 576 - 579
  • [43] Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Agents in Different Regional Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Zang, Li
    Han, Ying
    Chen, Lixian
    Hu, Daqing
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [44] Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes
    Franchi, Matteo
    Pellegrini, Giacomo
    Avogaro, Angelo
    Buzzetti, Giuliano
    Candido, Riccardo
    Cavaliere, Arturo
    Consoli, Agostino
    Marzona, Irene
    Mennini, Francesco Saverio
    Palcic, Stefano
    Corrao, Giovanni
    BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (03)
  • [45] Objective sleep characteristics and continuous glucose monitoring profiles of type 2 diabetes patients in real-life settings
    Zhao, Yan
    Zheng, Yuchan
    Tian, Yixin
    Yu, Qian
    Qin, Lijun
    Xu, Kai
    Sun, Biao
    Benedict, Christian
    Chen, Baoyi
    Wei, Lijun
    Tan, Xiao
    DIABETES OBESITY & METABOLISM, 2023, 25 (03): : 823 - 831
  • [46] Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center
    Sofra, Daniela
    DIABETES THERAPY, 2017, 8 (02) : 377 - 384
  • [47] Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice Study
    Salmen, Teodor
    Rizvi, Ali Abbas
    Rizzo, Manfredi
    Pietrosel, Valeria-Anca
    Bica, Ioana-Cristina
    Diaconu, Cosmina Theodora
    Potcovaru, Claudia Gabriela
    Salmen, Bianca-Margareta
    Coman, Oana Andreia
    Bobirca, Anca
    Stoica, Roxana-Adriana
    Stoian, Anca
    BIOMEDICINES, 2023, 11 (09)
  • [48] Monitoring and management of type 2 diabetes patients with renal disease: gap between knowledge and real-life practices
    Dejager, S.
    Blickle, J. -F.
    Fiquet, B.
    Penfornis, A.
    DIABETOLOGIA, 2013, 56 : S118 - S118
  • [49] Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center
    Daniela Sofra
    Diabetes Therapy, 2017, 8 : 377 - 384
  • [50] Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany
    Pscherer, Stephan
    Dippel, Franz-Werner
    Lauterbach, Silke
    Kostev, Karel
    PRIMARY CARE DIABETES, 2012, 6 (03) : 241 - 246
12345